Randomized phase II study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 29; no. 15_suppl; p. TPS176
Main Authors: Borad, M. J., Sigal, D., Uronis, H., Stephenson, J., Bahary, N., Rarick, M. U., DeMarco, L. C., Finnegan, T. J., Chiorean, E. G., Ryan, D. P., Cohn, A. L., Ulrich, B. K., Harish, V. C., Anderes, E. N., Ma, W. W., Yu, P. P., Sinicrope, F., Eng, C., Sunkara, U. K., Reddy, S. G.
Format: Journal Article
Language:English
Published: 20-05-2011
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2011.29.15_suppl.tps176